The use of monoclonal antibodies in the study and management of the interstitial lung diseases.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000954:Antigens, Surface / Q000032:analysis; D002454:Cell Differentiation; D002469:Cell Separation / Q000379:methods; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology / Q000628:therapy; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D007167:Immunotherapy; D007249:Inflammation; D007962:Leukocytes / Q000276:immunology / Q000473:pathology; D008168:Lung / Q000473:pathology; D008213:Lymphocyte Activation; D010641:Phenotype; D011658:Pulmonary Fibrosis / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D011994:Recombinant Proteins / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D007130:Immunoglobulin Idiotypes; D011994:Recombinant Proteins